(Q41600907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309095%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309095%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309095%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Shapiro F

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309095%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309095%20AND%20SRC:MED&resulttype=core&format=json

Surgical oncology clinics of North America

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309095%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309095%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309095%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

813-830

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309095%20AND%20SRC:MED&resulttype=core&format=json

Natural history and prognosis of untreated stage I epithelial ovarian carcinoma.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Tumor angiogenesis: an independent prognostic parameter in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

A review of second-look laparotomy for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

New gynecologic cancer staging

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Early ovarian cancer: treat now, later or never?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

The epidemiology of cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

Staging Laparotomy in Early Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930305-3

7 January 2021

10.1016/S1055-3207(18)30305-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309095%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference